President Emmanuel Macron

article

Pharmaceutical C-suite update

With two knighthoods in the last month, here EPR discusses…

21 June 2022 | By Hannah Balfour (European Pharmaceutical Review)

With two knighthoods in the last month, here EPR discusses five developments in the drug development community’s C-suite.

article

Ways to promote patient access as a European healthcare priority

We are experiencing a time of polarity in our healthcare…

22 December 2021 | By Catherine Owen (Bristol Myers Squibb)

We are experiencing a time of polarity in our healthcare systems with breakthrough treatment options developed, but access prohibited. Here, Catherine Owen, SVP of Major Markets at Bristol Myers Squibb, explains why, despite continued COVID-19 pressures, the time is ripe to rectify this situation.